Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam in Psychosis Risk
NCT06224530Recruiting
- Sponsor
- King's College London
- Start
- Jul 2024
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of levetiracetam in psychosis (3 arms), sponsored by King's College London. Primary endpoint: Regional Cerebral Blood Flow in the Hippocampus at 1 hour. Started Jul 2024; status: recruiting.
02
Drugs
levetiracetam
03
Conditions
psychosis
Beyond the preview
Go deeper on NCT06224530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06224530.